%0 Journal Article
%T Sentinel Node Mapping for Breast Cancer: Current Situation
%A Sergi Vidal-Sicart
%A Renato Vald¨¦s Olmos
%J Journal of Oncology
%D 2012
%I Hindawi Publishing Corporation
%R 10.1155/2012/361341
%X Axillary node status is a major prognostic factor in early-stage disease. Traditional staging needs levels I and II axillary lymph node dissection. Axillary involvement is found in 10%¨C30% of patients with T1 (<2£¿cm) tumours. Sentinel lymph node biopsy is a minimal invasive method of checking the potential nodal involvement. It is based on the assumption of an orderly progression of lymph node invasion by metastatic cells from tumour site. Thus, when sentinel node is free of metastases the remaining nodes are free, too (with a false negative rate lesser than 5%). Moreover, Randomized trials demonstrated a marked reduction of complications associated with the sentinel lymph node biopsy when compared with axillary lymph node dissection. Currently, the sentinel node biopsy procedure is recognized as the standard treatment for stages I and II. In these stages, this approach has a positive node rate similar to those observed after lymphadenectomy, a significant decrease in morbidity and similar nodal relapse rates at 5 years. In this review, the indications and contraindications of the sentinel node biopsy are summarized and the methodological aspects discussed. Finally, the new technologic and histologic developments allow to develop a more accurate and refinate technique that can achieve virtually the identification of 100% of sentinel nodes and reduce the false negative rate. 1. Introduction Breast cancer is the most common cancer in women worldwide. In 2010, it was estimated that in the USA there were nearly 210,000 new cases of invasive breast cancer and more than 40,000 deaths. Axillary node status is a major prognostic factor in early-stage disease, and this information is important for treatment. Traditional staging needs levels I and II axillary lymph node dissection. Axillary involvement is found in 10%¨C30% of patients with T1 (<2£¿cm) tumours. This rate reaches 45% for small T2 tumours (2.1¨C3£¿cm) and 55%¨C70% for larger tumours (>3£¿cm). Routine axillary lymphadenectomy adds the risk of lymphedema, sensory disturbances, and chronic pain. Sentinel lymph node biopsy is a minimal invasive method of checking the potential nodal involvement. It is based on the assumption of an orderly progression of lymph node invasion by metastatic cells from tumour site. Thus, the nodal basin is free of malignancy if the sentinel lymph node is not involved. Patients with metastasis to a sentinel node would undergo either immediate or delayed completion lymph node dissection. Randomized trials demonstrated a marked reduction of complications associated with the sentinel
%U http://www.hindawi.com/journals/jo/2012/361341/